{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:08:41Z","timestamp":1780628921030,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.eprac.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T11:30:28Z","timestamp":1649676628000},"page":"678-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly"],"prefix":"10.1016","volume":"28","author":[{"given":"Rok","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Gori\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Jane\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Jensterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eprac.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2010.7.FOCUS10168","article-title":"Pharmacological management of acromegaly: a current perspective","volume":"29","author":"Manjila","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","article-title":"Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire","volume":"90","author":"Rowles","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2022.04.002_bib3","first-page":"53","article-title":"Patient perspectives on the impact of acromegaly: results from individual and group interviews","volume":"8","author":"Gurel","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.eprac.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11102-019-01013-2","article-title":"Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider","volume":"23","author":"Geer","year":"2020","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11102-017-0835-5","article-title":"Development of ACRODAT\u00ae, a new software medical device to assess disease activity in patients with acromegaly","volume":"20","author":"van der Lely","year":"2017","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","article-title":"SAGIT\u00ae: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study","volume":"19","author":"Giustina","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.eprac.2022.04.002_bib7","doi-asserted-by":"crossref","unstructured":"van der Meulen M, Zamanipoor Najafabadi AH, Broersen LHA, et\u00a0al. State of the art of patient-reported outcomes in acromegaly or GH deficiency: a systematic review and meta-analysis. Preprint. Posted online December 6, 2021. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgab874","DOI":"10.1210\/clinem\/dgab874"},{"issue":"5","key":"10.1016\/j.eprac.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11102-019-00977-5","article-title":"Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT\u00ae validation study","volume":"22","author":"Giustina","year":"2019","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.eprac.2022.04.002_bib9","first-page":"3555","article-title":"International multicenter validation study of the SAGIT\u00ae instrument in acromegaly","volume":"106","author":"Giustina","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2022.04.002_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2017.00040","article-title":"Predictors of quality of life in acromegaly: no consensus on biochemical parameters","volume":"8","author":"Geraedts","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"5363849","DOI":"10.1155\/2020\/5363849","article-title":"Quality of life in patients with acromegaly before and after transsphenoidal surgical resection","volume":"2020","author":"Gu","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2022.04.002_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","article-title":"Treatment of acromegaly improves quality of life, measured by AcroQol","volume":"67","author":"Paisley","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib13","doi-asserted-by":"crossref","first-page":"e006898","DOI":"10.1136\/bmjopen-2014-006898","article-title":"Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea","volume":"5","author":"Chin","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.eprac.2022.04.002_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10.1016\/j.eprac.2022.04.002_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","article-title":"Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties","volume":"57","author":"Webb","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2022.04.002_bib16","doi-asserted-by":"crossref","unstructured":"Sawicka-Gutaj N, Zi\u00f3\u0142kowska P, Ziemnicka K, Szczepanek-Parulska E, Czarnywojtek A, Rucha\u0142a M. The SAGIT instrument: potential utility in treatment decision-making in acromegaly. Presented at: 22nd European Congress of Endocrinology; September 5-9, 2020; Online. Accessed March\u00a01, 2022. https:\/\/www.endocrine-abstracts.org\/ea\/0070\/ea0070aep573.htm","DOI":"10.1530\/endoabs.70.AEP573"},{"issue":"2","key":"10.1016\/j.eprac.2022.04.002_bib17","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.04.002_bib19","first-page":"1363","article-title":"Towards an earlier diagnosis of acromegaly and gigantism","volume":"10","author":"Sisco","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.04.002_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11102-016-0761-y","article-title":"Update on quality of life in patients with acromegaly","volume":"20","author":"Crespo","year":"2017","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.eprac.2022.04.002_bib21","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00701-016-2903-4","article-title":"Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis","volume":"158","author":"Starnoni","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"issue":"11","key":"10.1016\/j.eprac.2022.04.002_bib22","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess","volume":"89","author":"Biermasz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2022.04.002_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3122\/jabfm.2021.03.200593","article-title":"Health-related quality of life for people with acute and chronic illnesses during the COVID-19 pandemic","volume":"34","author":"O'Dwyer","year":"2021","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.04.002_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12877-021-02593-0","article-title":"Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease","volume":"21","author":"Voorend","year":"2021","journal-title":"BMC Geriatr"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234850","article-title":"Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic","volume":"15","author":"Ping","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.eprac.2022.04.002_bib26","first-page":"1047","article-title":"Impact of the COVID-19 pandemic on the quality of life of patients with Parkinson\u2019s disease and their caregivers: a single-center survey in Tochigi prefecture","volume":"11","author":"Suzuki","year":"2021","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.eprac.2022.04.002_bib27","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","article-title":"Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant","volume":"93","author":"Neggers","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.04.002_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-07-0356","article-title":"Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly","volume":"157","author":"T\u2019Sjoen","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2022.04.002_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02292","article-title":"Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly","volume":"155","author":"Hua","year":"2006","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22004803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22004803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:21Z","timestamp":1761516801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22004803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1530891X22004803"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.04.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}